Cargando…
Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria
BACKGROUND: The contrast between a high prevalence of chronic kidney disease (CKD) and the low incidence of end-stage renal disease highlights the need for new biomarkers of progression beyond albuminuria testing. Urinary proteomics is a promising method, but more studies focusing on progression rat...
Autores principales: | Øvrehus, Marius A, Zürbig, Petra, Vikse, Bjørn E, Hallan, Stein I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528848/ https://www.ncbi.nlm.nih.gov/pubmed/26257595 http://dx.doi.org/10.1186/s12014-015-9092-7 |
Ejemplares similares
-
Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria
por: Hallan, Stein I., et al.
Publicado: (2023) -
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012) -
Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018) -
Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018) -
Diseases of the Kidney and Urinary Derangements. Part II.—Albuminuria
Publicado: (1877)